USFDA granted approval to Aurobindo Pharma for Flucytosine Capsules

Aurobindo Pharma received its final approval from the US Food & Drug Administration (USFDA) to manufacture and market Flucytosine Capsules, 250 mg and 500 mg.

Flucytosine Capsules are used for the treatment of serious infections caused by susceptible strains of Candida and Cryptococcus. The Capsules are a generic version of Bausch Health’s Ancobon Capsules and the capsules will be launched in June 2020.

A total of 429 ANDA approvals has been granted to Aurobindo (401 Final approvals including 23 from Aurolife Pharma LLC and 28 tentative approvals) from USFDA.

  • Related Posts

    IIT Kanpur scientists’ research reveals how a promising vaccine booster switches on immune cells

    Kanpur: Scientists at IIT Kanpur have revealed how an experimental molecule called EP67 switches on an important receptor found on human immune cells. EP67 is a candidate “adjuvant”, an ingredient…

    Government takes steps to strengthen primary healthcare services

    The Union minister of state for health and family welfare, Prataprao Jadhav stated that the government has taken steps to strengthen primary healthcare services in the country. The ministry of…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    IIT Kanpur scientists’ research reveals how a promising vaccine booster switches on immune cells

    IIT Kanpur scientists’ research reveals how a promising vaccine booster switches on immune cells

    Government takes steps to strengthen primary healthcare services

    Government takes steps to strengthen primary healthcare services

    Operation Vajra: CBN thwarts Global Syndicate, seizes 12 Crore ‘Fighter Drug’ Tablets destined for Conflict Zones

    Operation Vajra: CBN thwarts Global Syndicate, seizes 12 Crore ‘Fighter Drug’ Tablets destined for Conflict Zones

    National Health Emergency: Telangana C-section Cluster Spark Critical Alarms as Substandard Drug Suspicions spread Nationwide

    National Health Emergency: Telangana C-section Cluster Spark Critical Alarms as Substandard Drug Suspicions spread Nationwide

    Star Bio Pharma Global strengthens its position in the global nutraceutical supply Chain

    Star Bio Pharma Global strengthens its position in the global nutraceutical supply Chain

    Chemists demand fair competition in pharma market amid online sales concerns

    Chemists demand fair competition in pharma market amid online sales concerns